RecruitingPhase 2NCT06701682

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PPD Development, LP
Intervention
Cohort A: vilobelimab(drug)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
20252028

Study locations (30)

Collaborators

Biomedical Advanced Research and Development Authority · InflaRx GmbH · Edesa Biotech Inc. · Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06701682 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials